OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice
Nasib Ervinna, Tomoya Mita, Eisuke Yasunari, et al.
Endocrinology (2013) Vol. 154, Iss. 3, pp. 1260-1270
Open Access | Times Cited: 163
Nasib Ervinna, Tomoya Mita, Eisuke Yasunari, et al.
Endocrinology (2013) Vol. 154, Iss. 3, pp. 1260-1270
Open Access | Times Cited: 163
Showing 26-50 of 163 citing articles:
The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory
Gemma Pujadas, Valeria De Nigris, Francesco Prattichizzo, et al.
Endocrine (2016) Vol. 56, Iss. 3, pp. 509-520
Open Access | Times Cited: 58
Gemma Pujadas, Valeria De Nigris, Francesco Prattichizzo, et al.
Endocrine (2016) Vol. 56, Iss. 3, pp. 509-520
Open Access | Times Cited: 58
DPP-IV inhibitor anagliptin exerts anti-inflammatory effects on macrophages, adipocytes, and mouse livers by suppressing NF-κB activation
Takanori Shinjo, Yusuke Nakatsu, Misaki Iwashita, et al.
AJP Endocrinology and Metabolism (2015) Vol. 309, Iss. 3, pp. E214-E223
Open Access | Times Cited: 56
Takanori Shinjo, Yusuke Nakatsu, Misaki Iwashita, et al.
AJP Endocrinology and Metabolism (2015) Vol. 309, Iss. 3, pp. E214-E223
Open Access | Times Cited: 56
Anti-atherosclerosis and hyperlipidemia effects of herbal mixture, Artemisia iwayomogi Kitamura and Curcuma longa Linne, in apolipoprotein E-deficient mice
Hyun‐Soo Shin, Jongmin Han, Hyeong-Geug Kim, et al.
Journal of Ethnopharmacology (2014) Vol. 153, Iss. 1, pp. 142-150
Closed Access | Times Cited: 56
Hyun‐Soo Shin, Jongmin Han, Hyeong-Geug Kim, et al.
Journal of Ethnopharmacology (2014) Vol. 153, Iss. 1, pp. 142-150
Closed Access | Times Cited: 56
Impact of Sitagliptin on Carotid Intima-Media Thickness in Patients With Coronary Artery Disease and Impaired Glucose Tolerance or Mild Diabetes Mellitus
Shinji Ishikawa, Masayuki Shimano, Masato Watarai, et al.
The American Journal of Cardiology (2014) Vol. 114, Iss. 3, pp. 384-388
Closed Access | Times Cited: 54
Shinji Ishikawa, Masayuki Shimano, Masato Watarai, et al.
The American Journal of Cardiology (2014) Vol. 114, Iss. 3, pp. 384-388
Closed Access | Times Cited: 54
Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient mice
Hotimah Masdan Salim, Daiju Fukuda, Yasutomi Higashikuni, et al.
Vascular Pharmacology (2015) Vol. 79, pp. 16-23
Closed Access | Times Cited: 53
Hotimah Masdan Salim, Daiju Fukuda, Yasutomi Higashikuni, et al.
Vascular Pharmacology (2015) Vol. 79, pp. 16-23
Closed Access | Times Cited: 53
Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation
Seung Hee Choi, Sungmi Park, Chang Joo Oh, et al.
Vascular Pharmacology (2015) Vol. 73, pp. 11-19
Closed Access | Times Cited: 51
Seung Hee Choi, Sungmi Park, Chang Joo Oh, et al.
Vascular Pharmacology (2015) Vol. 73, pp. 11-19
Closed Access | Times Cited: 51
Anti‐atherogenic and anti‐inflammatory properties of glucagon‐like peptide‐1, glucose‐dependent insulinotropic polypepide, and dipeptidyl peptidase‐4 inhibitors in experimental animals
Tsutomu Hirano, Yusaku Mori
Journal of Diabetes Investigation (2016) Vol. 7, Iss. S1, pp. 80-86
Open Access | Times Cited: 49
Tsutomu Hirano, Yusaku Mori
Journal of Diabetes Investigation (2016) Vol. 7, Iss. S1, pp. 80-86
Open Access | Times Cited: 49
Asymmetric Hydrocyanation of Alkenes without HCN
Xiuxiu Li, Cai You, Jiaxin Yang, et al.
Angewandte Chemie International Edition (2019) Vol. 58, Iss. 32, pp. 10928-10931
Closed Access | Times Cited: 48
Xiuxiu Li, Cai You, Jiaxin Yang, et al.
Angewandte Chemie International Edition (2019) Vol. 58, Iss. 32, pp. 10928-10931
Closed Access | Times Cited: 48
Anagliptin ameliorates high glucose- induced endothelial dysfunction via suppression of NLRP3 inflammasome activation mediated by SIRT1
Tiechao Jiang, Dongli Jiang, Lirong Zhang, et al.
Molecular Immunology (2019) Vol. 107, pp. 54-60
Closed Access | Times Cited: 44
Tiechao Jiang, Dongli Jiang, Lirong Zhang, et al.
Molecular Immunology (2019) Vol. 107, pp. 54-60
Closed Access | Times Cited: 44
DPP-4 Inhibitors as Potential Candidates for Antihypertensive Therapy: Improving Vascular Inflammation and Assisting the Action of Traditional Antihypertensive Drugs
Jianqiang Zhang, Qiuyue Chen, Jixin Zhong, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 43
Jianqiang Zhang, Qiuyue Chen, Jixin Zhong, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 43
Dipeptidyl peptidase 4 inhibitors: Applications in innate immunity?
Roger Yazbeck, Simone Jaenisch, Catherine A. Abbott
Biochemical Pharmacology (2021) Vol. 188, pp. 114517-114517
Open Access | Times Cited: 36
Roger Yazbeck, Simone Jaenisch, Catherine A. Abbott
Biochemical Pharmacology (2021) Vol. 188, pp. 114517-114517
Open Access | Times Cited: 36
Dipeptidyl peptidase-4 inhibition and vascular repair by mobilization of endogenous stem cells in diabetes and beyond
Gian Paolo Fadini, Angelo Avogaro
Atherosclerosis (2013) Vol. 229, Iss. 1, pp. 23-29
Closed Access | Times Cited: 51
Gian Paolo Fadini, Angelo Avogaro
Atherosclerosis (2013) Vol. 229, Iss. 1, pp. 23-29
Closed Access | Times Cited: 51
Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury
Yuichi Terawaki, Takashi Nomiyama, Takako Kawanami, et al.
Cardiovascular Diabetology (2014) Vol. 13, Iss. 1
Open Access | Times Cited: 47
Yuichi Terawaki, Takashi Nomiyama, Takako Kawanami, et al.
Cardiovascular Diabetology (2014) Vol. 13, Iss. 1
Open Access | Times Cited: 47
Dipeptidyl peptidase IV (DPP-4) inhibition alleviates pulmonary arterial remodeling in experimental pulmonary hypertension
Jian Xu, Jingjing Wang, Mengyu He, et al.
Laboratory Investigation (2018) Vol. 98, Iss. 10, pp. 1333-1346
Open Access | Times Cited: 45
Jian Xu, Jingjing Wang, Mengyu He, et al.
Laboratory Investigation (2018) Vol. 98, Iss. 10, pp. 1333-1346
Open Access | Times Cited: 45
Myotube formation is affected by adipogenic lineage cells in a cell-to-cell contact-independent manner
Yuki Takegahara, Keitaro Yamanouchi, Katsuyuki Nakamura, et al.
Experimental Cell Research (2014) Vol. 324, Iss. 1, pp. 105-114
Closed Access | Times Cited: 43
Yuki Takegahara, Keitaro Yamanouchi, Katsuyuki Nakamura, et al.
Experimental Cell Research (2014) Vol. 324, Iss. 1, pp. 105-114
Closed Access | Times Cited: 43
A Randomized Controlled Trial Comparing the Effects of Sitagliptin and Glimepiride on Endothelial Function and Metabolic Parameters: Sapporo Athero-Incretin Study 1 (SAIS1)
Hiroshi Nomoto, Hideaki Miyoshi, Tomoo Furumoto, et al.
PLoS ONE (2016) Vol. 11, Iss. 10, pp. e0164255-e0164255
Open Access | Times Cited: 43
Hiroshi Nomoto, Hideaki Miyoshi, Tomoo Furumoto, et al.
PLoS ONE (2016) Vol. 11, Iss. 10, pp. e0164255-e0164255
Open Access | Times Cited: 43
The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction
Mei-Tzu Wang, Sheng‐Che Lin, Pei‐Ling Tang, et al.
Cardiovascular Diabetology (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 40
Mei-Tzu Wang, Sheng‐Che Lin, Pei‐Ling Tang, et al.
Cardiovascular Diabetology (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 40
Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes
Xia Wang, Peilin Zheng, Gan Huang, et al.
Clinical and Experimental Medicine (2018) Vol. 18, Iss. 4, pp. 473-480
Open Access | Times Cited: 40
Xia Wang, Peilin Zheng, Gan Huang, et al.
Clinical and Experimental Medicine (2018) Vol. 18, Iss. 4, pp. 473-480
Open Access | Times Cited: 40
The protective role of DPP4 inhibitors in atherosclerosis
Hengdao Liu, Lingli Guo, Junhui Xing, et al.
European Journal of Pharmacology (2020) Vol. 875, pp. 173037-173037
Closed Access | Times Cited: 38
Hengdao Liu, Lingli Guo, Junhui Xing, et al.
European Journal of Pharmacology (2020) Vol. 875, pp. 173037-173037
Closed Access | Times Cited: 38
Nickel-Catalyzed Asymmetric Hydrocyanation of Allenes
Jinguo Long, Jihui Gao, Xianjie Fang
Organic Letters (2020) Vol. 22, Iss. 2, pp. 376-380
Closed Access | Times Cited: 36
Jinguo Long, Jihui Gao, Xianjie Fang
Organic Letters (2020) Vol. 22, Iss. 2, pp. 376-380
Closed Access | Times Cited: 36
Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets
Defne Bayık, Cynthia F. Bartels, Katreya Lovrenert, et al.
Cancer Research (2022) Vol. 82, Iss. 22, pp. 4274-4287
Open Access | Times Cited: 20
Defne Bayık, Cynthia F. Bartels, Katreya Lovrenert, et al.
Cancer Research (2022) Vol. 82, Iss. 22, pp. 4274-4287
Open Access | Times Cited: 20
Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies
Andrea Angeli, В. Г. Карцев, Anthi Petrou, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 316-316
Open Access | Times Cited: 19
Andrea Angeli, В. Г. Карцев, Anthi Petrou, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 316-316
Open Access | Times Cited: 19
Attenuation of Endothelial Dysfunction in Diabetes Mellitus: An Integral Characteristic of Anti-Diabetic Medications
Chidiebere V. Ugwueze
Journal of Diabetology (2025) Vol. 16, Iss. 1, pp. 1-13
Open Access
Chidiebere V. Ugwueze
Journal of Diabetology (2025) Vol. 16, Iss. 1, pp. 1-13
Open Access
The Dipeptidyl Peptidases 4, 8, and 9 in Mouse Monocytes and Macrophages: DPP8/9 Inhibition Attenuates M1 Macrophage Activation in Mice
Yannick Waumans, Gwendolyn Vliegen, L. Maes, et al.
Inflammation (2015) Vol. 39, Iss. 1, pp. 413-424
Open Access | Times Cited: 38
Yannick Waumans, Gwendolyn Vliegen, L. Maes, et al.
Inflammation (2015) Vol. 39, Iss. 1, pp. 413-424
Open Access | Times Cited: 38
Adipose Tissue Dysfunction and Inflammation in Cardiovascular Disease
Nina Wronkowitz, Tania Romacho, Henrike Sell, et al.
Frontiers of hormone research (2014), pp. 79-92
Closed Access | Times Cited: 36
Nina Wronkowitz, Tania Romacho, Henrike Sell, et al.
Frontiers of hormone research (2014), pp. 79-92
Closed Access | Times Cited: 36
